Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of <i>Helicobacter pylori</i>.

Mori, Naoyoshi; Nishiura, Yuuki; Suga, Daisuke; Moritani, Isao; Yamanaka, Yutaka; Ooya, Yumi; Inoue, Hidekazu; Takase, Koujirou; Hioki, Masato; Shiraki, Katsuya

Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori.

Mori, Naoyoshi; Nishiura, Yuuki; Suga, Daisuke; Moritani, Isao; Yamanaka, Yutaka; Ooya, Yumi; Inoue, Hidekazu; Takase, Koujirou; Hioki, Masato; Shiraki, Katsuya.

Afiliação

Mori N; Department of Pharmacy, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Nishiura Y; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Suga D; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Moritani I; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Yamanaka Y; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Ooya Y; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Inoue H; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Takase K; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Hioki M; Department of Pharmacy, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.
Shiraki K; Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.